| Titre : | Prognostic factors for 495 nonoperative esophageal squamous cancer patients receiving IMRT plus chemotherapy: A retrospective analysis (2022) |
| Auteurs : | Q. Gao ; Z.-Y. Liu ; Y. Cheng ; X.-K. Di ; Y.-M. Zhang ; X.-C. Sun ; X.-J. Xia ; X.-L. Ge |
| Type de document : | Article |
| Dans : | Cancer/Radiothérapie (vol. 26, no. 8, Novembre 2022) |
| Article en page(s) : | p. 1002-1007 |
| Note générale : | https://doi-org.ezproxy.vinci.be/10.1016/j.canrad.2022.01.008 |
| Langues: | Anglais |
| Descripteurs : |
HE Vinci Analyse de survie ; Chimioradiothérapie ; Pronostic ; Radiothérapie conformationnelle avec modulation d'intensité (RCMI) ; Survie ; Tumeurs de l'oesophage |
| Mots-clés: | Carcinome épidermoïde de l’œsophage |
| Résumé : | Purpose Chemoradiotherapy is regarded as a standard scheme for inoperable and unresectable esophageal cancers. Our aims were to explore the prognostic factors relevant to esophageal squamous cell carcinoma (ESCC) following intensity-modulated radiation therapy (IMRT) plus chemotherapy. Material and methods Totally 495 ESCC patients undergoing IMRT combined with chemotherapy in our hospital between 2011 and 2020 were retrospectively analyzed. Potential clinical prognosis-related factors were assessed by uni- and multivariate analyses. Results The median overall survival (OS) and progression-free survival (PFS) of the ESCC patients were 2.25 and 1.24years, respectively. Uni- and multivariate analyses demonstrated the relevant independent prognostic factors of OS and PFS were gender, T stage, N stage, clinical stage, and tumor location (P |
| Disponible en ligne : | Oui |
| En ligne : | https://login.ezproxy.vinci.be/login?url=https://www.sciencedirect.com/science/article/pii/S1278321822000920 |
Bibliothèques HE Vinci
